IMWG: The Challenge of Double Refractory Disease
IMWG Myeloma Experts debate the latest trends in treatment
June 10, 2015
Vienna Austria
Since 2001, the International Myeloma Working Group’s achievements have changed the landscape of myeloma research. This collaborative effort has brought about breakthroughs in treatment options and diagnostic systems that prolong lives. The IMWG consists of nearly 200 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects. Their work focuses on protocols to provide a more durable remission for myeloma patients while improving quality of life, and addressing the needs of both myeloma patients and the physicians who treat them.
Previous Post
IMWG: Drug Costs and Access
Next Post
How common is toxoplasmosis infection?




